27757003|t|Off-Label Use of Dexmedetomidine for the Treatment of Delirium in the Intensive Care Unit.
27757003|a|OBJECTIVE: Evaluate recent clinical studies involving the use of dexmedetomidine (DEX) infusion for the treatment of delirium in the intensive care unit (ICU). METHODS: A literature search was conducted to identify peer-reviewed articles in MEDLINE (1966-June 2016) using the terms sedation, analgesic, dexmedetomidine, delirium, and critically ill adult patients. RESULTS: Two studies in the ICU setting reported the potential benefits of DEX for managing agitation during weaning from mechanical ventilation. One pilot study and a clinical trial reported the use of DEX in the treatment of ICU delirium. CONCLUSION: Further studies are required to evaluate the use of DEX treatment in critically ill patients presenting with delirium.
27757003	17	32	Dexmedetomidine	Chemical	MESH:D020927
27757003	54	62	Delirium	Disease	MESH:D003693
27757003	156	171	dexmedetomidine	Chemical	MESH:D020927
27757003	173	176	DEX	Chemical	MESH:D020927
27757003	208	216	delirium	Disease	MESH:D003693
27757003	394	409	dexmedetomidine	Chemical	MESH:D020927
27757003	411	419	delirium	Disease	MESH:D003693
27757003	425	439	critically ill	Disease	MESH:D016638
27757003	446	454	patients	Species	9606
27757003	531	534	DEX	Chemical	MESH:D020927
27757003	548	557	agitation	Disease	MESH:D011595
27757003	659	662	DEX	Chemical	MESH:D020927
27757003	687	695	delirium	Disease	MESH:D003693
27757003	761	764	DEX	Chemical	MESH:D020927
27757003	778	792	critically ill	Disease	MESH:D016638
27757003	793	801	patients	Species	9606
27757003	818	826	delirium	Disease	MESH:D003693
27757003	Negative_Correlation	MESH:D020927	MESH:D016638
27757003	Negative_Correlation	MESH:D020927	MESH:D003693
27757003	Negative_Correlation	MESH:D020927	MESH:D011595

